HempFusion Wellness Inc.

HempFusion Wellness Inc. is a pioneering player in the hemp-derived CBD industry, positioned to surpass global standards. The company boasts a robust portfolio of premium consumer brands, including HempFusion™, Sagely Naturals™, Apothecanna™, and Probulin Probiotics™. Notably, the latter is recognized as one of the fastest-growing probiotics companies in the U.S. As a testament to their commitment to quality, HempFusion is among the few CBD companies to achieve Self-Affirmed GRAS status. Their product range, consisting of 112 SKUs, spans USDA Organic Certified Tinctures, FDA Drug Listed Over-The-Counter (OTC) Topicals, probiotic supplements, skin care products, and more. With a strong emphasis on research and development, the company currently has 43 products under development. HempFusion Wellness products are available across 18,000+ U.S. retail locations and in several international markets, including China, Mexico, Ireland, United Kingdom, United Arab Emirates, South Korea, and Canada. Additionally, customers can purchase their offerings through the respective brand websites, The Probulin Store on Amazon.com, and Alibaba’s Tmall.com, emphasizing their global reach. Founded in 2015 and headquartered in the United States, HempFusion recently secured a $3.00M Post-IPO Debt investment on 01 March 2022. This funding underscores the growing confidence in the company's potential and its ability to capitalize on the expanding CBD market. With its innovative product range and strategic market presence, HempFusion Wellness Inc. is well-positioned to capitalize on the burgeoning opportunities in the agriculture and nutrition industries.